Literature DB >> 5347827

Protein binding and vascular activity of diazoxide.

E M Sellers, J Koch-Weser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5347827     DOI: 10.1056/NEJM196911202812102

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

Review 3.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

Review 4.  Diazoxide: a review of its pharmacological properties and therapeutic use in hypertensive crises.

Authors: 
Journal:  Drugs       Date:  1971       Impact factor: 9.546

5.  Myocardial inactivity of therapeutic concentrations of hydralazine and diazoxide.

Authors:  J Koch-Weser
Journal:  Experientia       Date:  1974-02-15

6.  In vivo binding of p,p'-DDE to human serum proteins.

Authors:  W P Schoor
Journal:  Bull Environ Contam Toxicol       Date:  1973-02       Impact factor: 2.151

Review 7.  Pharmacokinetics and response to diazoxide in renal failure.

Authors:  R M Pearson
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

8.  The use of diazoxide in hypertensive crises with particular reference to the control of hypertension in severe renal failure.

Authors:  T H Mathew; P Kincaid-Smith
Journal:  Drugs       Date:  1971       Impact factor: 9.546

9.  Renal function, protein binding and pharmacological response to diazoxide.

Authors:  R M Pearson; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

10.  Development of extrapyramidal symptoms in hypertensive patients treated with diazoxide.

Authors:  D Neary; H Thurston; J E Pohl
Journal:  Br Med J       Date:  1973-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.